Kendall Forbes receives 8,952 GRDN (GRDN) restricted stock units award

Rhea-AI Filing Summary

Forbes Kendall reported acquisition or exercise transactions in this Form 4 filing.

Guardian Pharmacy Services insider Kendall Forbes received an equity award. Forbes was granted 8,952 restricted stock units of Class A common stock at no cash cost, which will vest in full on March 1, 2029. After this grant, Forbes directly holds 799,928 shares or units of Class A common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Forbes Kendall

(Last) (First) (Middle)

300 GALLERIA PARKWAY SE, SUITE 800

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/01/2026		A		8,952(1)	A	$0.00	799,928	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of restricted stock units that upon vesting are settled on a one-for-one basis in shares of Class A common stock, vesting in full on March 1, 2029.

Remarks:

Executive Vice President, Sales & Operations

	/s/ Douglas Towns, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Kendall Forbes report in this Form 4 for GRDN?

Kendall Forbes reported receiving 8,952 restricted stock units of Guardian Pharmacy Services Class A common stock. These units were granted at no cash cost and increase Forbes’ direct holdings to 799,928 shares or units after the transaction.

Is the GRDN Form 4 transaction a purchase or an award?

The GRDN Form 4 shows an equity award, not an open-market purchase. Code "A" indicates a grant or other acquisition, in this case restricted stock units that vest into Class A common shares on a one-for-one basis at a future date.

When do Kendall Forbes’ GRDN restricted stock units vest?

The restricted stock units granted to Kendall Forbes vest in full on March 1, 2029. At that time, each unit will settle into one share of Guardian Pharmacy Services Class A common stock, subject to any applicable service or employment conditions.

How many Guardian Pharmacy Services shares does Kendall Forbes hold after this filing?

After the reported award, Kendall Forbes directly holds 799,928 shares or equivalent units of Guardian Pharmacy Services Class A common stock. This total includes the 8,952 newly granted restricted stock units that will convert into shares upon vesting in 2029.

What price was paid for the GRDN restricted stock units granted to Kendall Forbes?

The restricted stock units were granted at a stated price of $0.00 per unit. This reflects a compensatory equity award rather than a cash purchase, with value realized later when units vest and convert into Class A common stock shares.